Testing an experimental injection for weight management
Part of Hormones & metabolism clinical trials.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be 24 or higher, and you must weigh more than 60 kg (about 132 lbs) if you're male, or more than 50 kg (about 110 lbs) if you're female.
- You must have been trying to control your weight through diet and exercise for at least 3 months, with no major weight changes in the past 3 months.
- You must agree to use reliable birth control and avoid donating sperm or eggs during the study and for 6 months after it ends.
- You must not have certain health conditions, such as diabetes, severe heart problems, or a history of depression or suicidal thoughts.
- You must not have taken certain medications recently, such as weight-loss drugs, diabetes drugs, or vaccines, within a specified time before screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.